Representation and Medication Use in Juvenile Idiopathic Arthritis

Study Overview
=================
Brief Summary
-----------------
According to the International League of Associations for Rheumatology classification, Juvenile Idiopathic Arthritis (JIA) comprises a heterogeneous group of arthritis of unknown cause and with onset before 16 years of age, characterized by joint inflammation lasting for 6 or more weeks. Few studies exist regarding the care experience of children affected by this rheumatic condition. On the other hand, methotrexate and biologics constitute the primary treatment for children with JIA. As with adults undergoing the same treatment, adherence is critical. Difficulties for children to take the drugs have been reported. Notwithstanding, if adherence promotion in pediatric chronic conditions has been the subject of recommendations with regard to care management, the investigators lack information to understand the grounds for adherence specifically in JIA. In order to understand and decipher the parent-child adherence mechanisms and practices, the RUMAJI study will be conducted. Indeed, improving the relational approach between children and their caregivers as well as unrestricted drug adherence involves researching and understanding how appropriation of the disease and treatment could be achieved.

Official Title
-----------------
Representation and Medication Use in Juvenile Idiopathic Arthritis - RUMAJI

Conditions
-----------------
Juvenile Idiopathic Arthritis

Intervention / Treatment
-----------------
* Other: Interviews with parents of children with juvenile idiopathic arthritis
* Other: Interviews with children with juvenile idiopathic arthritis
* Other: Interviews with Physicians


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion criteria: all JIA forms all treatment type (NSAIDs, MTX, bDMARDs) Exclusion criteria: - none

Ages Eligible for Study
-----------------
Minimum Age: 1 Year
Maximum Age: 17 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Physicians<br>3 paediatricians and 3 rheumatologists | Other: Interviews with Physicians<br>* Interviews with Physicians<br>|
| Parents<br>Parents | Other: Interviews with parents of children with juvenile idiopathic arthritis<br>* Interviews with parents of children with juvenile idiopathic arthritis<br>|
| Children<br>Children | Other: Interviews with children with juvenile idiopathic arthritis<br>* Interviews with children with juvenile idiopathic arthritis<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Interview with parents | Interview with parents to learn about role of parents in the management of juvenile idiopathic arthritis in their children | 1 day | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Interview with children | Interview with children to learn about role of children in the management of their juvenile idiopathic arthritis | 1 day | 
| Interview with physicians | Interview with physicians to learn about role of physicians in the management of juvenile idiopathic arthritis | 1 day | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
Role of parents, children and physician, Qualitative, Interview, Juvenile idiopathic arthritis, Adherence, mechanisms of adherence in juvenile idiopathic arthritis